Cerus CERS
NASDAQ CERS
$2.51 -0.03 (-1.18%)
As of: Sep 9, 2026 · 3:59 PM EDT

Cerus (CERS) Cash from Investing Activities (2010 - 2026)

Cerus' (CERS) quarterly Cash from Investing Activities came in at $12.9 million in Q2 2026, up 1281.45% year-over-year from $931339.7 in Q2 2025, and up 30.49% quarter-over-quarter from $9.9 million in Q1 2026.

Analysis

Cerus (CERS) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Cerus has disclosed Cash from Investing Activities across 17 years of filings, most recently posting $12.9 million for Q2 2026.

  • In Q2 2026, Cash from Investing Activities rose 1281.45% year-over-year to $12.9 million; the TTM figure through Jun 2026 stood at $18.8 million (up 496.86% YoY), while the FY2025 annual figure was -$6.2 million, up 24.17% from the prior year.
  • Cash from Investing Activities came in at $12.9 million for Q2 2026 at Cerus, up from $9.9 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $12.9 million in Q2 2026 to a low of -$7.3 million in Q4 2024.
  • Average Cash from Investing Activities over 5 years is $1.4 million, with a median of -$682000.0 recorded in 2023.
  • The largest YoY upside for Cash from Investing Activities was 1851.64% in 2024 against a maximum downside of 405.15% in 2024.
  • Over 5 years, Cash from Investing Activities stood at $7.4 million in 2022, then climbed by 11.28% to $8.2 million in 2023, then tumbled by 188.68% to -$7.3 million in 2024, then soared by 81.09% to -$1.4 million in 2025, then jumped by 1033.67% to $12.9 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were $12.9 million in Q2 2026, $9.9 million in Q1 2026, and -$1.4 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -673.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -26.60 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -1.62 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -639.00 Mn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -1.96 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -193.20 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -222.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 329.80 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -108.50 Mn
10 Cerus 504.42 Mn 448.16 Mn 29.53 Mn 12.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.87 Mn
Mar 31, 2026 9.86 Mn
Dec 31, 2025 -1.38 Mn
Sep 30, 2025 -2.51 Mn
Jun 30, 2025 -1.09 Mn
Mar 31, 2025 -1.19 Mn
Dec 31, 2024 -7.29 Mn
Sep 30, 2024 4.82 Mn
Jun 30, 2024 -7.11 Mn
Mar 31, 2024 1.45 Mn
Dec 31, 2023 8.22 Mn
Sep 30, 2023 -275,000.00
Jun 30, 2023 2.33 Mn
Mar 31, 2023 -1.65 Mn
Dec 31, 2022 7.38 Mn
Sep 30, 2022 -2.07 Mn
Jun 30, 2022 -5.48 Mn
Mar 31, 2022 8.62 Mn
Dec 31, 2021 -40.29 Mn
Sep 30, 2021 21.73 Mn